India's drug regulator has given Hetero Labs the green light to manufacture and market its generic version of Gilead Science's experimental COVID-19 treatment remdesivir, the Indian pharmaceutical company said on Sunday.
FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease , during the outbreak of the coronavirus disease , in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake/File Photo
- India’s drug regulator has given Hetero Labs the green light to manufacture and market its generic version of Gilead Science’s experimental COVID-19 treatment remdesivir, the Indian pharmaceutical company said on Sunday. The drug, which will be marketed under the brand name Covifor, will likely be priced at 5,000 to 6,000 rupees for a 100 milligram dose, Hetero said.
India's Cipla Ltd has also received approval from the Drug Controller General of India to manufacture and market the drug, according to a reportGilead Sciences Inc signed non-exclusive licensing pacts last month with five generic drugmakers based in India and Pakistan to expand the supply of its COVID-19 treatment.
The pacts allow Jubilant Life Sciences Ltd, Cipla, Hetero Labs, Mylan NV and Ferozsons Laboratories Ltd to make and sell the drug in 127 countries.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
China says Galwan Valley belongs to them, blames India over brawlBoth India and China blame each other for the clash in a disputed Himalayan region that left 20 Indian soldiers dead and more than 70 injured.
Read more »
Exclusive: Amazon signals entry into alcohol delivery in India with nod in key state - documentAmazon.com Inc has secured clearance to deliver alcohol in India's eastern state of West Bengal, according to a document seen by Reuters, signalling the U.S. e-commerce giant's first foray into the country's multi-billion-dollar sector.
Read more »
India, China accuse each other of violating de facto borderIndia and China on Saturday each traded accusations that the other had violated their shared de facto border, an area that this week became the site of the deadliest clash in half a century between the two nuclear-armed giants.
Read more »
How Drones Are Helping India Fight The Coronavirus PandemicDemand for drones has soared as civic authorities, state governments and the police sought out these flying machines to help them manage the pandemic in a myriad of ways.
Read more »
India reports record rise in coronavirus cases; Delhi cancels all medical staff leaveIndia reported a record jump in coronavirus infections on Saturday, a day after the government in the capital New Delhi ordered hospitals to cancel any leave and have workers return to duty immediately.
Read more »
Timeline: the Line of Actual Control between China and IndiaStand-off between Indian and Chinese border troops is the culmination of festering tensions between the two sides over territory that has been contested for more than a century.
Read more »